… Jean-Marc Classe, Virginie Bordes, Loic Campion, Herve Mignotte, François Dravet,
Jean Leveque, Christine Sagan, Pierre François Dupre, Gilles Body, and Sylvia Giard …

Purpose In multiple myeloma, many prognostic parameters have been proposed. However,
all of these predict shorter survival. To identify patients with a longer life expectancy, we …

Purpose Cytogenetics is an important prognostic parameter in multiple myeloma (MM). Patients
presenting with either t (4; 14) or del (17p) are known to have a short event-free survival (…

OBJECTIVE: Our objective was to compare statistical and clinical methods for the evaluation
of five self-monitoring blood glucose (SMBG) meters. RESEARCH DESIGN AND METHODS…

Context: After unsuccessful surgery, medullary thyroid carcinoma (MTC) may be fatal or
remain stable for decades, and precise survival predictors are needed. Objective: This study …

… Olivier Decaux, Laurence Lodé, Florence Magrangeas, Catherine Charbonnel, Wilfried
Gouraud, Pascal Jézéquel, Michel Attal, Jean-Luc Harousseau, Philippe Moreau, Régis …

Purpose No effective therapy is currently available for the management of patients with
metastatic medullary thyroid carcinoma (MTC). The efficacy of pretargeted radioimmunotherapy (…

… Caroline Rousseau, Anne Devillers, Christine Sagan, Ludovic Ferrer, Boumédiène Bridji,
Loıc Campion, Myriam Ricaud, Emmanuelle Bourbouloux, Isabelle Doutriaux, Martine …

Gene prognostic meta-analyses should benefit from breast tumour genomic data obtained
during the last decade. The aim was to develop a user-friendly, web-based application, based …

Many trials in myeloma are stratified on cytogenetic abnormalities. Among them, the most
commonly chosen are the t(4;14), the del(17p), and the t(14;16). If data are well established for t…